Table S1.
Psychoanaleptic and psycholeptic prescription in the five clusters
| n (% of cluster population) | Cluster 1 (less obstruction) n=1,310 |
Cluster 2 (less obstruction, psychoanaleptic users, high comorbidity) n=238 |
Cluster 3 (greater obstruction, no pneumonia history) n=1,189 |
Cluster 4 (greater obstruction, high comorbidity, pneumonia history) n=374 |
Cluster 5 (greater obstruction, low BMI) n=144 |
|---|---|---|---|---|---|
| Psychoanaleptics | |||||
| Any | 0 (0.0) | 238 (100) | 172 (14.5) | 66 (17.6) | 23 (16.0) |
| Antidepressants | 0 (0.0) | 212 (89.1) | 147 (12.4) | 64 (17.1) | 22 (15.3) |
| Psychostimulants for ADHD/nootropics | 0 (0.0) | 33 (13.9) | 27 (2.3) | 3 (0.8) | 1 (0.7) |
| Antidementia medication | 0 (0.0) | 7 (2.9) | 4 (0.3) | 2 (0.5) | 0 (0.0) |
| Psycholeptics | |||||
| Any | 123 (9.4) | 102 (42.9) | 142 (11.9) | 65 (17.4) | 18 (12.5) |
| Antianxiety medication | 82 (6.3) | 68 (28.6) | 100 (8.4) | 38 (10.2) | 13 (9.0) |
| Hypnotics/sedatives | 53 (4.0) | 40 (16.8) | 56 (4.7) | 31 (8.3) | 6 (4.2) |
| Antipsychotics | 10 (0.8) | 21 (8.8) | 12 (1.0) | 9 (2.4) | 1 (0.7) |
| Benzodiazepine/derivative | 70 (5.3) | 59 (24.8) | 87 (7.3) | 34 (9.1) | 9 (6.3) |
Abbreviation: ADHD, attention-deficit hyperactivity disorder; BMI, body mass index.